首页> 外文期刊>Pediatric asthma, allergy & immunology >Parents' Fears and Concerns Toward Inhaled Corticosteroid Treatment for Their Asthmatic Children
【24h】

Parents' Fears and Concerns Toward Inhaled Corticosteroid Treatment for Their Asthmatic Children

机译:父母对哮喘儿童吸入糖皮质激素治疗的担忧和担忧

获取原文
获取原文并翻译 | 示例
           

摘要

Asthma is the most prevalent chronic illness among children. Although inhaled corticos-teroids are the recommended controller drug for treatment and prevention of childhood asthma attacks, long-term adherence is low. Our study aimed to determine the prevalence of fears and concerns of parents of children with asthma toward corticosteroid treatment, and the relationship of these concerns with level of adherence with therapy. Fifty mothers of asthmatic children aged 1-13 years, attending the Primary Care Pediatric Center in Beer-Sheva, were included in the study. Long-term inhaled corticosteroids were recommended to all the children. Four mothers refused to participate. Forty-six mothers were interviewed using a structured questionnaire regarding the presence of fears and concerns toward the use of inhaled corticosteroids. They were divided into two groups according to the presence or absence of fears and concerns toward the treatment. Data regarding asthma history, so-cioeconomic status, level of adherence to treatment, sources of information regarding asthma treatment, and the use of alternative medicine were also collected. Fourteen (30.4%) mothers reported fears and concerns related to chronic treatment of their children with inhaled corticosteroids (concerned mothers). Thirty-two mothers (69.6%) expressed no fears regarding this treatment (confident mothers). Both groups were similar in their socioeconomic status. Five of 14 (35.7%) concerned mothers compared with only one of 32 (3.1%) confident mothers reduced the recommended dosage (p = 0.004). More concerned mothers tend to receive information from lay literature, friends, and relatives and to use alternative homeopathic treatment compared with confident mothers. Among concerned mothers, the reasons mentioned for their concerns were risk of addiction (64%), weight gain or stunting (50%), toxicity (35%), and irritability or hyperactivity (57%). Maternal fears and concerns about the potential side effects of prolonged inhaled corticosteroid treatment on their asthmatic children are fairly common and tend to decrease their adherence to treatment.
机译:哮喘是儿童中最普遍的慢性疾病。尽管吸入皮质类固醇是推荐的控制药物,用于治疗和预防儿童哮喘发作,但长期依从性较低。我们的研究旨在确定哮喘患儿父母对皮质类固醇治疗的恐惧和担忧的患病率,以及这些担忧与依从性与治疗水平之间的关系。该研究纳入了50名1-13岁哮喘儿童的母亲,他们在比尔谢瓦的初级保健儿科中心就读。建议所有儿童长期吸入糖皮质激素。四位母亲拒绝参加。使用结构化调查表对46名母亲进行了采访,调查涉及是否存在对吸入性糖皮质激素使用的恐惧和担忧。根据是否存在对治疗的恐惧和担忧将他们分为两组。还收集了有关哮喘病史,社会经济状况,对治疗的依从性水平,有关哮喘治疗的信息来源以及使用替代药物的数据。十四名(30.4%)母亲报告了对吸入式糖皮质激素对其孩子进行长期治疗的担忧和忧虑(有关母亲)。三十二名母亲(69.6%)对这种治疗没有表示恐惧(自信的母亲)。两组的社会经济地位相似。 14位关注的母亲中有5位(35.7%)与32位自信的母亲中只有1位(3.1%)降低了推荐剂量(p = 0.004)。与有信心的母亲相比,更多关心母亲的母亲倾向于从非专业文献,朋友和亲戚那里获得信息,并使用其他顺势疗法。在有关的母亲中,提到他们担心的原因是成瘾的风险(64%),体重增加或发育迟缓(50%),毒性(35%)以及易怒或多动(57%)。孕产妇对哮喘儿童长期吸入皮质类固醇激素长期吸入治疗的潜在担忧和担忧相当普遍,并倾向于降低其对治疗的依从性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号